Information relating to the compensation elements of Mr. Aymeric Le CHATELIER, interim Chief Executive Officer from 1st January 2020 to 30 June 2020 - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
    • Media Statements
    • Media Library
  • Investors  arrow down
    < Back
    • Investors
    • Financial Results
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Reports and Accounts
    • Regulated Information

    • Combined Shareholders’ Meeting 2024 (pre announcement page launch)

       Featured Image
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category
    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Slovakia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Stories
Back

Post navigation

Previous
Next

Information relating to the compensation elements of Mr. Aymeric Le CHATELIER, interim Chief Executive Officer from 1st January 2020 to 30 June 2020

Information relating to the compensation elements of Mr. Aymeric Le CHATELIER, interim Chief Executive Officer from 1st January 2020 to 30 June 2020

- 11 February 2021 - 0 mins read

Post navigation

Previous
Next

Related Documents

  • Information-relative-aux-éléments-de-rémunération-de-A.-le-Chatelier-VEN   Download  (167 KB)

Related Reports and Accounts

Global Quality Policy
18 June 2024 0 mins read

Global Quality Policy
EHS Policy
18 June 2024 0 mins read

EHS Policy
ISO 45001-2018
18 June 2024 0 mins read

ISO 45001-2018
ISO 14001-2015
18 June 2024 0 mins read

ISO 14001-2015
Supplier screening
18 June 2024 0 mins read

Supplier screening
Lobbying activities, association management and governance framework for public policy engagement
18 June 2024 0 mins read

Lobbying activities, association management and governance framework for public policy engagement
D E & I achievements for 2023
18 June 2024 0 mins read

D E & I achievements for 2023
Modern Slavery Statement
18 June 2024 0 mins read

Modern Slavery Statement
Human rights position paper
18 June 2024 0 mins read

Human rights position paper
ISO 37001 Certification
18 June 2024 0 mins read

ISO 37001 Certification

IPN price

€101.50

 €-0.40 (-0.39%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Responsibility
  • Patients
  • Stories
  • Annual Report
  • Contact us
Global
LinkedIn Twitter Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2023

You are now leaving the Ipsen group website.To continue, please click on Continue?

Continue